Sonaglia, A.; Comoretto, R.; Pasut, E.; Treppo, E.; Del Frate, G.; Colatutto, D.; Zabotti, A.; De Vita, S.; Quartuccio, L.
Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak. Viruses 2022, 14, 1462.
https://doi.org/10.3390/v14071462
AMA Style
Sonaglia A, Comoretto R, Pasut E, Treppo E, Del Frate G, Colatutto D, Zabotti A, De Vita S, Quartuccio L.
Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak. Viruses. 2022; 14(7):1462.
https://doi.org/10.3390/v14071462
Chicago/Turabian Style
Sonaglia, Arianna, Rosanna Comoretto, Enrico Pasut, Elena Treppo, Giulia Del Frate, Donatella Colatutto, Alen Zabotti, Salvatore De Vita, and Luca Quartuccio.
2022. "Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak" Viruses 14, no. 7: 1462.
https://doi.org/10.3390/v14071462
APA Style
Sonaglia, A., Comoretto, R., Pasut, E., Treppo, E., Del Frate, G., Colatutto, D., Zabotti, A., De Vita, S., & Quartuccio, L.
(2022). Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak. Viruses, 14(7), 1462.
https://doi.org/10.3390/v14071462
